Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.

Prota AE, Danel F, Bachmann F, Bargsten K, Buey RM, Pohlmann J, Reinelt S, Lane H, Steinmetz MO.

J Mol Biol. 2014 Apr 17;426(8):1848-60. doi: 10.1016/j.jmb.2014.02.005. Epub 2014 Feb 11.

PMID:
24530796
2.

Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole.

Lovering AL, Gretes MC, Safadi SS, Danel F, de Castro L, Page MG, Strynadka NC.

J Biol Chem. 2012 Sep 14;287(38):32096-102. doi: 10.1074/jbc.M112.355644. Epub 2012 Jul 19.

3.

Asparaginyl-tRNA synthetase pre-transfer editing assay.

Danel F, Caspers P, Nuoffer C, Härtlein M, Kron MA, Page MG.

Curr Drug Discov Technol. 2011 Mar;8(1):66-75.

PMID:
21091430
4.

Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.

Pohlmann J, Vasilevich NI, Glushkov AI, Kellenberger L, Shapiro S, Caspers P, Page MG, Danel F.

Bioorg Med Chem Lett. 2010 Aug 1;20(15):4635-8. doi: 10.1016/j.bmcl.2010.05.110. Epub 2010 Jun 8.

PMID:
20576430
5.

Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change.

Sukuru SC, Crepin T, Milev Y, Marsh LC, Hill JB, Anderson RJ, Morris JC, Rohatgi A, O'Mahony G, Grøtli M, Danel F, Page MG, Härtlein M, Cusack S, Kron MA, Kuhn LA.

J Comput Aided Mol Des. 2006 Mar;20(3):159-78. Epub 2006 Apr 28.

PMID:
16645791
6.

Development of a virtual screening method for identification of "frequent hitters" in compound libraries.

Roche O, Schneider P, Zuegge J, Guba W, Kansy M, Alanine A, Bleicher K, Danel F, Gutknecht EM, Rogers-Evans M, Neidhart W, Stalder H, Dillon M, Sjögren E, Fotouhi N, Gillespie P, Goodnow R, Harris W, Jones P, Taniguchi M, Tsujii S, von der Saal W, Zimmermann G, Schneider G.

J Med Chem. 2002 Jan 3;45(1):137-42.

PMID:
11754585
7.

Effect of divalent metal cations on the dimerization of OXA-10 and -14 class D beta-lactamases from Pseudomonas aeruginosa.

Danel F, Paetzel M, Strynadka NC, Page MG.

Biochemistry. 2001 Aug 7;40(31):9412-20.

PMID:
11478911
8.

Evidence of dimerisation among class D beta-lactamases: kinetics of OXA-14 beta-lactamase.

Danel F, Frère JM, Livermore DM.

Biochim Biophys Acta. 2001 Mar 9;1546(1):132-42.

PMID:
11257516
9.

Crystal structure of the class D beta-lactamase OXA-10.

Paetzel M, Danel F, de Castro L, Mosimann SC, Page MG, Strynadka NC.

Nat Struct Biol. 2000 Oct;7(10):918-25.

PMID:
11017203
10.

OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa.

Danel F, Hall LM, Duke B, Gur D, Livermore DM.

Antimicrob Agents Chemother. 1999 Jun;43(6):1362-6.

11.

Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.

Danel F, Hall LM, Livermore DM.

J Antimicrob Chemother. 1999 Mar;43(3):339-44.

PMID:
10223588
12.

The structure and function of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Haemophilus influenzae.

Hennig M, Dale GE, D'arcy A, Danel F, Fischer S, Gray CP, Jolidon S, Müller F, Page MG, Pattison P, Oefner C.

J Mol Biol. 1999 Mar 26;287(2):211-9.

PMID:
10080886
13.

OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.

Danel F, Hall LM, Gur D, Livermore DM.

Antimicrob Agents Chemother. 1998 Dec;42(12):3117-22.

14.

Unusual tazobactam-sensitive AmpC beta-lactamase from two Escherichia coli isolates.

Babini GS, Danel F, Munro SD, Micklesen PA, Livermore DM.

J Antimicrob Chemother. 1998 Jan;41(1):115-8.

PMID:
9511046
15.

Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.

Villar HE, Danel F, Livermore DM.

J Antimicrob Chemother. 1997 Sep;40(3):365-70.

PMID:
9338488
16.

OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.

Danel F, Hall LM, Gur D, Livermore DM.

Antimicrob Agents Chemother. 1997 Apr;41(4):785-90.

17.

pH effects on the inhibition of extended-spectrum and classical TEM beta-lactamases by penicillanic acid sulphones.

Fornara AM, Danel F, Livermore DM.

J Antimicrob Chemother. 1997 Jan;39(1):89-93.

PMID:
9044033
18.

[The sorting of linens: everyone's business...].

Delestraint M, Davril CM, Danel F.

Rev Infirm. 1995 Dec;(19):63-5. French. No abstract available.

PMID:
8850843
19.

OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

Danel F, Hall LM, Gur D, Livermore DM.

Antimicrob Agents Chemother. 1995 Aug;39(8):1881-4.

20.

Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.

Danel F, Hall LM, Gur D, Akalin HE, Livermore DM.

J Antimicrob Chemother. 1995 Feb;35(2):281-94.

PMID:
7759392
21.

Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK.

Jenks PJ, Hu YM, Danel F, Mehtar S, Livermore DM.

J Antimicrob Chemother. 1995 Jan;35(1):235-6. No abstract available.

PMID:
7768779
22.

Potential use of robots in endoscopic neurosurgery.

Benabid AL, Lavallee S, Hoffmann D, Cinquin P, Demongeot J, Danel F.

Acta Neurochir Suppl (Wien). 1992;54:93-7.

PMID:
1595416
23.

Is there any future for robots in neurosurgery?

Benabid AL, Hoffmann D, Lavallee S, Cinquin P, Demongeot J, Le Bas JF, Danel F.

Adv Tech Stand Neurosurg. 1991;18:3-45. Review. No abstract available.

PMID:
1930374

Supplemental Content

Support Center